Drug Trial Radar · NCT02485704
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Last checked: Nov 20, 2026Latest source record: May 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
280
Actual
Start
May 10, 2017
Primary completion
Aug 3, 2018
Study completion Aug 3, 2018
Sponsor
- Lead sponsor
- ParaPRO LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Concentrics Research
- First posted
- Jun 30, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment.
Conditions
- Scabies
Interventions
spinosad topical suspension, 0.9%Drug
Topically apply 0.9% suspension up to 120 mL (enough to cover the body from the neck down to the soles of the feet). One application for six hours.
PlaceboOther
Placebo is the same as the drug minus the active ingredient spinosad (vehicle). Topically apply up to 120 mL (enough to cover the body from the neck down to the soles of the feet). One application for six hours.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Index Subjects Completely Cured of Scabies After a Single TreatmentTime frame: 28 days after treatment
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Saint Joseph's Clinical Research
Anaheim, California
Long Beach Clinical Trial Services
Long Beach, California
The Chappel Group Research
Kissimmee, Florida
DermDox Centers for Dermatology
Hazleton, Pennsylvania
Paddington Testing Company
Philadelphia, Pennsylvania
West Houston Clinical Research Service
Houston, Texas
Discovery Clinical Trials
McAllen, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.